Phase 3 eosinophilic esophagitis Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
eosinophilic esophagitis
Dr. Falk Pharma GmbH308 enrolled26 locationsNCT06596252
Recruiting
Phase 3
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Eosinophilic Esophagitis (EoE)
Regeneron Pharmaceuticals20 enrolled8 locationsNCT07112378
Not Yet Recruiting
Phase 3
Two food group elimination diet versus swallowed fluticasone for the management of adult eosinophilic esophagitis, a single- centred randomised prospective study
eosinophilic esophagitis
Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital194 enrolled1 locationACTRN12619000141145